Kingfisher shares plummet as sales decline

Kingfisher shares sank on Tuesday after the DIY specialist announced falling sales and profit amid difficult trading conditions.

Despite increasing market share, Kingfisher’s sales fell 1.5% in the year to January 2025 and operating profit fell 29%.

The results were a real kick in the teeth for investors, and shares were down over 13% at the time of writing.

“Kingfisher is stuck in reverse gear. The B&Q owner is one of the most shorted stocks on the UK market as hedge funds bet that its problems can’t be fixed in the current fragile retail environment. They have been right so far, with the shares slumping even further on its latest set of results,” Russ Mould, investment director at AJ Bell.

Thierry Garnier, Chief Executive Officer of Kingfisher, used the first line of his comment on results to highlight market share growth in all six of their key regions. Although this shows Kingfisher are doing a good job of increasing their prominence in the industry, the fact is that the industry they operate in is facing extreme pressure.

“The B&Q and owner has been turning the screw on its competitors and eked out market share growth in all regions, but it is profit that investors really care about,” said Derren Nathan, head of equity research Hargreaves Lansdown.

“There’s only so long that discounting can be sustained for. France in particular was impacted, with retail profit slumping over 30%, with Poland being the bright spot. However, the UK still dominates and here performance was broadly flat. With higher labour costs around the corner and consumer sentiment under pressure, the Group has come out with conservative guidance for this year’s pre-tax profit in the £480mn-£540mn range, 6% behind forecasts at the mid-point.

Innovative Eyewear records best ever quarter with Reebok smart eyewear set to launch in Q2 2025

Innovative Eyewear Inc. (NASDAQ:LUCY), the developer of smart eyewear under multiple premium brands including Lucyd, Nautica, Eddie Bauer, and Reebok, has announced its financial results for the full year 2024, highlighting substantial revenue growth and margin improvements.

The company reported net revenue of $1,636,440 for the year ended 31 December 2024, representing a 42% increase from $1,152,479 in 2023.

The fourth quarter of 2024 saw revenue reach $690,688 – the company’s highest quarterly figure since inception and a 12% increase compared to the same period in 2023.

This growth was primarily driven by increased unit sales volume following the launch of co-branded collections and the Lucyd Armor safety smart glasses line.

Early sales of the safety glasses appear promising, and investors will be looking forward to the launch of Reebok-branded smart eyewear in Q2 2025. The safety glasses range was released midway through the fourth quarter, so the full quarterly impact of the new range will not be felt until Q1 2025.

The company has materially increased its distribution networks, and its products are now stocked by numerous eyewear outlets and ‘big box’ retailers.

Lucyd smart eyewear is now also available on Walmart.com, Target.com, BestBuy.com, DicksSportingGoods.com, Brookstone.com, and eBay.

“Our 2024 fourth quarter revenue was our best quarter yet, and we have continued the trend of outperforming sales each quarter on a year-over-year basis, for the last 18 months,” said Harrison Gross, CEO of Innovative Eyewear Inc.

“As we look ahead to 2025, we believe we are well positioned to build on our momentum and significantly grow both our total revenues and our market share. I am particularly excited about the potential of our upcoming Reebok® product lines which we will be launching in 2025 coupled with the continued significant traction of the Lucyd ArmorTM smart safety glasses.”

Gross profit margins improved significantly to 13% in 2024, compared with a negative 10% in 2023. This 23 percentage point improvement was largely attributable to reduced costs for frames and lenses, which contributed 13 and 8 percentage points, respectively, to the margin enhancement.

Innovative Eyewear has invested heavily in marketing, which is reflected in an overall loss for the year. That said, increased sales in Q4 put the company on an upward trajectory towards breakeven, should sales growth momentum continue. The upcoming quarters could prove particularly interesting for the Tekcapital portfolio company.

The company ended 2024 with $2,628,987 in cash and cash equivalents, down from $4,287,447 a year earlier.

During the fourth quarter, Innovative Eyewear achieved several milestones, including the launch of the first ANSI-certified smart safety glasses for all-day wear, expansion to over 400 optical stores, and a new retail partnership with Nebraska Furniture Mart.

AIM movers: FD Technologies increases ARR and Wellnex Life shares slide

0

URU Metals (LON: URU) shares have bounced back after a decline just before the 25-for-one share split on 24 March. The adjusted share price doubled to 8p, which is the highest it has been for more than two years.  

Online building products retailer CMO Group (LON: CMO) is leaving AIM on 27 March. Despite selling ahead of that date there has been enough buying interest for the share price to perk up 33.96% to 3.55p.

Software provider FD Technologies (LON: FDP) increased annualised recurring revenues by 13% to £81.8m in the year to February 2025. Trading was at the top end of guidance and the loss was lower than expected. Net cash was £56m at the end of February 2024. There are new opportunities in capital markets, defence and industrial IoT and management believes that annualised recurring revenues could grow by one-fifth this year. The share price increased 12.6% to 1872p.

Insurance and employee benefits provider Personal Group Holdings (LON: PGH) grew revenues of continuing operations by 13% to £43.8m. Both the insurance and employee benefits divisions made progress with annualised recurring revenues reaching £43.4m. There is cash of £27.4m, which is £17m more than regulatory and group requirements. This enables the dividend to be raised from 11.7p/share to 16.6p/share and Canaccord Genuity has raised its expectation for 2025 from 19p/share to 19.7p/share. Cash should still increase. Investment in new insurance products and the employee benefits platform hapi will help to drive further growth over the long-term. The share price rose 11.3% to 236p, which is the highest it has been since 2022.

FALLERS

Galileo Resources (LON: GLR) says the phase 3 drilling results from 75%-owned Shingada copper gold project warrants progression to phase 4 drilling on the main fault. Mineralised dilation zones were confirmed. However, assay results were inconclusive in some areas due to poor diamond drill core owing to unfavourable ground conditions. The share price slipped 17.1% to 0.85p.

Wellnex Life (LON: WNX) shares started trading on Friday at 31p each, having raised £5.22m at 31.75p. The share price fell to 29p on Monday and has slipped a further 8.62% to 26.5p. The ASX-listed consumer healthcare company has an agreement with Haleon to supply paracetamol products that are sold under the Panadol brand, as well as its own brand Pain Away, the second largest provider of topical pain relief products in Australia.

Empyrean Energy (LON: EME) says the Wilson River-1 well has reached total depth. Petrophysical analysis is ongoing, and the results will be compared with existing wells. The share price is 2.56% lower at 0.095p, having been 0.085p earlier.

Marketing services provider The Mission Group (LON: TMG) improved continuing operation revenues by 2% to £75.9m, while underlying pre-tax profit increased from £4.2m to £5.1m. Net debt was reduced to £9.5m. That is before the disposal of April Six for up to £17.4m. Share buybacks are continuing. The share price fell 5.36% to 26.5p.

High palm oil price boosts MP Evans profit

0

Oil palm plantations operator MP Evans (LON: MPE) continues its strong first half performance into the second half as a higher crude palm oil price and improved gross margins meant that profit jumped in 2024.

The AIM-quoted company reported revenues increasing from $307.4m to $352.8m, while pre-tax profit jumped from $73.5m to $111.7m. The dividend was raised from 45p/share to 52.5p/share.

There was a 13% increase is crude palm oil sales prices to $823/tonne, and they are currently $870/tonne.

The company’s own production rose, but crop processed was slightly lower at 1.61 million tonnes because less third-party crop was bought in and processed at the six mills. That change in mix helped gross margin to rise. The relatively immature plants provide scope for further increases in MP Evans’ own production.

Cavendish does not expect MP Evans to maintain its profit in 2025, but this is based on a crude palm oil price of $750/tonne, which is the assumed price for 2026 and 2027 as well.

In Indonesia, there is a B40 biodiesel mandate that makes a 40% mix with palm oil-based fuel mandatory. That could increase demand by two million tonnes. However, the crop levels should improve this year because of better weather conditions. Even so, it appears that the palm oil price could remain strong, and the realised prices might beat the forecast.

The share price rose 6% to 1015p. Cavendish has a sum of the parts share price valuation of 1545p.

A 2025 pre-tax profit of $93.3m is forecast, rising to $97.3m in 2027. This will allow steady increases in dividends to continue, while cash is likely to rise. Net cash could increase from $46.3m to $77.7m the end of 2025. That provides firepower to add more land.

Murray International Trust: Elevator Pitch

Martin Connaghan, Co-Manager of Murray International outlines the trust’s strategy and objectives and highlights some key themes within the portfolio.

FTSE 100 jumps after storming US rally

The FTSE 100 jumped on the tailcoats of US equities on Tuesday after a tech rebound drove a sharp increase in the S&P 500 and Dow Jones overnight.

London’s leading index was 0.7% higher at the time of writing. The rally was broad with around 80% of the FTSE 100’s constituents trading in positive territory.

“There is nothing better than a solid day on Wall Street to lift investor sentiment across the pond,” said Russ Mould, investment director at AJ Bell.

“A 2.3% gain in the Nasdaq and 1.8% advance in the S&P 500 yesterday created the right kind of backdrop to put European markets on the front foot. All the major indices in Europe moved higher on Tuesday.”

US technology shares were the driving force behind yesterday’s rally, as beaten-down names such as Tesla, Palantir, and AMD caught the attention of bargain hunters.

London’s lack of mega-cap technology shares meant that if the FTSE 100 was to emulate Wall Street’s strength, it would have to rely on similarly cyclical sectors.

Housebuilders, property, and energy stocks took on the mantle.

Shell added a significant number of points to the index after it announced a strategy ‘to become simpler, more resilient and more competitive’.

The strategy was received well by investors and shares rose 2% on Tuesday.

“In a short statement ahead of its capital markets day, oil & gas giant Shell revealed that it’s upping its shareholder distribution of operating cash flows from the 30-40% range through the cycle up to 40-50%,” said Derren Nathan, head of equity research Hargreaves Lansdown.

“Dividend growth of 4% per year is being targeted but it’s share buybacks that will be the focus of increased payouts. And it’s also trying to maximise the cash generation that drives shareholder distributions.”

Housebuilders and property shares played a large part in the FTSE 100’s rally, with investors picking up shares such as Persimmon, Segro, and Taylor Wimpey near multi-year lows.

“Property-related shares were also in demand, including Segro at the top of the FTSE risers’ list and many housebuilders looking strong. Segro announced a data centre joint venture, giving investors a different spin on the AI theme,” Russ Mould explained.

Kingfisher was the FTSE 100’s top faller after announcing falling sales for the year to January 2025. Shares were 14% lower at the time of writing.

Broadcom, Taylor Wimpey, and high-conviction global income with Murray International Trust

The UK Investor Magazine was delighted to welcome Martin Connaghan, Co-Portfolio Manager of the Murray International Trust, for a deep dive into the trust and its approach to building a high-conviction global income portfolio.

Find out more about the Murray International Trust here.

We start by exploring the trust’s geographical weighting and why the Murray International Trust is underweight the United States.

Martin provides insight into the trust’s stock selection process and how they blend bottom-up research with positioning for macro influences such as tariffs and AI.

We discuss individual portfolio companies, including Broadcom and Taiwan Semiconductor and how the trust has been managing its positions in some of the portfolio’s largest holdings.

Martin finishes off by outlining what excites him about the year ahead and what keeps him up at night.

Fevertree shares jump as improved margins and increased US sales drive profit growth

Premium mixer company Fevertree Drinks plc has reported a significant improvement in profitability in 2024 as revenue growth in the US and improved margins helped boost the bottom line.

Once a darling of UK small-cap investors, Fevertree suffered a period of slow and falling sales, which saw shares fall from grace in 2021, never to recover.

Today’s 7% jump in shares would suggest investors are mildly optimistic things could be about the improve for the tonic water specialist.

The London-listed firm saw its Fever-Tree brand revenue growth accelerate to 7% in the second half of the year, delivering 4% growth for the full year on a constant currency basis. 

This was driven primarily by the company’s performance in the United States, where revenue grew by 12%.

Fevertree reported a substantial 540 basis point improvement in gross margin, which contributed to a 66% increase in Adjusted EBITDA to £50.7 million, in line with market expectations. The company’s EBITDA margin rose by 530 basis points to 13.7%.

This is all welcome news for investors.

The company’s strong financial performance has enabled it to recommend a final dividend of 11.12 pence per share, representing a 2% increase year over year. 

In addition, investors will be delighted to see Fevertree has extended its share buyback programme by an additional £29 million, bringing the total to be returned to shareholders over FY25 to £100 million.

US growth 

Cracking America isn’t easy but, despite problems in the UK, Fevertree has successful established a strong presence and the region is now the group’s single largest geography in terms of revenue.

However, in a strategic shift in their approach to the US, Fevertree announced a significant post-year-end development in the long-term strategic partnership with drinks giant Molson Coors on 30 January 2025 who will have exclusive sales, distribution, and production rights for the Fever-Tree brand in the United States.

The partnership aims to leverage Molson Coors’ scale and expertise to accelerate Fever-tree’s growth in the US market, capitalising on opportunities across both alcoholic and non-alcoholic categories.

“In return for handing over a stake in its business, Fevertree’s getting access to Coors’ broad production, distribution and marketing resources,” explained Aarin Chiekrie, equity analyst, Hargreaves Lansdown.

“It’s hoped that this will help drive the next leg of growth in the US, which has already become the tonic-maker’s largest market.”

Fevertree recognised £5.0 million in exceptional items relating to the transition to this partnership during the reporting period.

Fevertree’s Outlook

Following the announcement of the strategic partnership with Molson Coors, Fevertree expects to deliver strong Group revenue and EBITDA growth over the medium term. However, the company has cautioned that FY25 will be a transition year for the US business.

Fevertree reaffirmed guidance, stating they are comfortable with consensus expectations of low single-digit Group revenue growth and approximately 12% Group Adjusted EBITDA margin for the coming year.

Investors seemed content with the update, and shares traded at the highest level since October 2024 in early trading.

FTSE 100 gives up gains after Trump signals tariff ‘flexibility’

The FTSE 100 gave up gains on Monday after hopes that President Trump would take a more targeted approach to tariffs lifted sentiment in early trade. However, UK-centric concerns mounted as the session progressed, dragging the index into the red.

Donald Trump’s suggestion that there could be some ‘flexibility’ in reciprocal tariffs marks a step down in Trump’s approach, although tensions around trade still remain.

Nonetheless, signs that Trump may still be using tariffs as a negotiating tactic—albeit taking them further than he did in his first term—buoyed equity bulls on Monday.

The FTSE 100 started the session strongly, but the rally faded as the session progressed. London’s leading index was 0.1% higher at the time of writing, while S&P 500 futures jumped over 1%.

Trump’s change in approach to tariffs would still leave metals in his sights, and copper prices reacted accordingly on Monday, helping provide support for London mining stocks.

“Mining stocks were the key driver for the FTSE 100 as Antofagasta, Anglo American and Glencore topped the leader board thanks to stronger copper prices,” said Russ Mould, investment director at AJ Bell.

“The base metal has been on a strong run of late as markets worry about the impact of tariffs, with copper traders racing to snap up supplies in case Trump imposes new levies akin to what’s already happened with aluminium and steel.”

Strength in China-centric stocks was offset by those companies with exposure to the UK as investors prepared for this week’s Spring Statement. Property companies were notably weaker, although the losses were relatively benign.

JD Sports was the top faller after analysts at Deutsche Bank slashed their price target to 85p. JD was 4% lower at 72p at the time of writing.

Polar Capital Technology Trust was among the risers as investors picked the trust’s stock up after a sharp sell-off in line with a pullback in US tech shares. The trust’s top ten holdings include Nvidia, Microsoft, Meta, Apple, and Broadcom.

AIM movers: Positive Sea Lion news for Rockhopper Exploration and Wishbone Gold slumps after return from suspension

0

Rockhopper Exploration (LON: RKH) says Navitas, its partner in the Sea Lion joint venture in the Falkland Islands, has released a resource report. Phases one and two of the development remain the same with the development of 319mmbbl gross in the northern area of the field. Phase three will take the total production peak to 150mmbbl/day. The initial phase of 170mmbbl should reach final investment decision by the middle of 2025. It will take $1.4bn to reach first oil. The progress has pushed up the share price rose 12.3% to 42.55p.

Third quarter revenues at machine learning technology company Insig AI (LON: INSG) has grown third quarter by 64% to £131,000 compared to the second quarter. Fourth quarter revenues are expected to be £224,000. There is increasing engagement with customers and additional personnel are being recruited. To help fund this, £350,000 has been raised at 16p/share, including subscriptions by chief executive Richard Bernstein and chairman John Wilson. There is also an equity funding facility of £350,000 provided by Richard Bernstein, which gives him the right to subscribe for shares at 20p each. The share price is 9.23% higher at 17.75p.

Totally (LON: TLY) interim chief executive Prasad Godbole has bought 640,833 shares at 3.9p each and medical director John McMullan has acquired 4.17 million shares in the healthcare company at a range of prices between 3.0625p and 3.749p. The share price improved 6.67% to 4p.

Infrastructure-as-a-service provider eEnergy Group (LON: EAAS) has won two LED lighting contracts worth £572,000 as well as being appointed to the LASER Public Sector Framework for LED lighting. This framework will help to access work in the public sector, including school, the NHS and local authorities. The share price is 6.1% ahead at 4.35p.

Shares in Big Technologies (LON: BIG) have recovered following last week’s slump following the suspension of boss Sara Murray and current litigation. Neudi Kapital has a 10.5% stake. The share price increased 6.39% to 68.3p.

FALLERS

Shares in Wishbone Gold (LON: WSBN) have returned from suspension 42.2% down at 0.105p after the proposed reverse takeover of Evrensel Global Natural Resources was terminated. Anthony Moore has left the board, and David Lenigas has joined as a consultant. A placing has raised £700,000 at 0.1p/share. The company requires £500,000 to pay for costs and other liabilities. One of the operating subsidiaries is being restructured and £190,000 of the cash is required to pay the reduced liabilities. The focus will be on gold prospects in Australia, particularly those near to the Telfer project owned by Greatland Gold (LON: GGP).

Cannabis medicines developer Celadon Pharmaceuticals (LON: CEL) chief executive and 39.5% shareholder intended to propose the removal of the chairman and four non-executive directors at a general meeting. This is because they oppose his wish to leave AIM. The four non-executives have resigned and there will be a general meeting to propose the AIM cancellation. If this resolution passes, the chairman will resign, and JP Jenkins is likely to provide a matched bargain facility. The share price slumped 28.6% to 10p.

Trading in Sovereign Metals (LON: SVML) shares has been halted ahead of a fundraising. The plan is to raise A$40m at A$0.85/share. This will be invested in the development of the Kasiya rutile graphite project. The share price declined 10.4% to 43p.

Diagnostics company Abingdon Health (LON: ABDX) improved interim revenues by 28% to £3.1m, including four months from CS Lifesciences, and second half is stronger than expected. Contract development income was weak in the first half due to deferral of decisions, but new business has been won. Full year revenues are expected to rise from £6.1m to £8.5m, but Zeus has raised its forecast loss from £1.5m to £2.7m. Profitability is not expected until 20262-27. The share price fell 13.8% to 6.25p.